Boston Scientific Corp (BSX): Operating Cash Flow

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2012-12-31, 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$4.53B
Year ended 2025-12-31
$4.53B
Trailing 12 months to 2026-06-30
+43.8%
3-year compound annual growth
+24.6%
5-year compound annual growth
+20.7%
10-year compound annual growth
2007-12-31: $934.00M2008-12-31: $1.22B2009-12-31: $835.00M2010-12-31: $325.00M2011-12-31: $1.01B2012-12-31: $1.28B2013-12-31: $1.11B2014-12-31: $1.27B2015-12-31: $691.00M2016-12-31: $1.18B2017-12-31: $1.43B2018-12-31: $310.00M2019-12-31: $1.84B2020-12-31: $1.51B2021-12-31: $1.87B2022-12-31: $1.53B2023-12-31: $2.50B2024-12-31: $3.44B2025-12-31: $4.53B$4.53B
2007-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$4.53B+32.0%2026-02-17, From 2025-01-01
2024-12-31$3.44B+37.2%2026-02-17, From 2024-01-01
2023-12-31$2.50B+64.0%2026-02-17, From 2023-01-01
2022-12-31$1.53B-18.4%2025-02-18, From 2022-01-01
2021-12-31$1.87B+24.0%2024-02-20, From 2021-01-01
2020-12-31$1.51B-17.9%2023-02-23, From 2020-01-01
2019-12-31$1.84B+492.3%2022-02-23, From 2019-01-01
2018-12-31$310.00M-78.3%2021-02-23, From 2018-01-01
2017-12-31$1.43B+20.6%2020-02-25, From 2017-01-01
2016-12-31$1.18B+71.1%2019-02-19, From 2016-01-01
2015-12-31$691.00Mn/c2018-02-20, From 2015-01-01
2014-12-31$1.27B+14.3%2017-02-23, From 2014-01-01
2013-12-31$1.11B-13.3%2016-02-24, From 2013-01-01
2012-12-31$1.28Bn/c2015-02-25, From 2012-01-01
2011-12-31$1.01B+210.2%2014-02-26, From 2011-01-01
2010-12-31$325.00M-61.1%2013-02-22, From 2010-01-01
2009-12-31$835.00M-31.3%2012-02-17, From 2009-01-01
2008-12-31$1.22B+30.2%2011-02-17, From 2008-01-01
2007-12-31$934.00Mn/a2010-02-26, From 2007-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Boston Scientific Corp (BSX)2025-12-31$4.53B+32.0%
Becton Dickinson & Co (BDX)2025-09-30$3.43B-10.8%
3M Co (MMM)2025-12-31$2.31B+26.8%
Stryker Corp (SYK)2025-12-31$5.04B+18.9%
Medline Inc. (MDLN)2025-12-31$1.74B-1.4%
Baxter International Inc (BAX)2025-12-31$845.00M-17.1%
Solventum Corp (SOLV)2025-12-31$369.00M-68.9%
ResMed Inc (RMD)2026-06-30$1.81B+3.1%
Dexcom Inc (DXCM)2025-12-31$1.44B+45.6%

Compare BSX, BDX, MMM, SYK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗